What is the recommended management for a 60-year-old male with a ruptured renal artery aneurysm complicated by acute kidney injury (GFR ~35 mL/min/1.73 m², creatinine 2.1 mg/dL, BUN 78 mg/dL), metabolic acidosis (anion gap 17), elevated transaminases (AST 249 U/L, ALT 97 U/L) and hyperbilirubinemia (total bilirubin 6.1 mg/dL)?

Management of Ruptured Renal Artery Aneurysm with Multi-Organ Dysfunction

This patient requires immediate angioembolization for hemorrhage control, followed by aggressive supportive care including fluid resuscitation, avoidance of nephrotoxins, correction of metabolic acidosis, and close monitoring for potential renal replacement therapy. 1

Immediate Hemorrhage Control

Angioembolization (AE) is the definitive first-line intervention for ruptured renal artery aneurysm in hemodynamically stable or stabilizable patients. 1

• AE demonstrates superior outcomes compared to nephrectomy, with better preservation of renal function and similar transfusion requirements and re-bleeding rates 1
• The procedure should be performed as sub-selectively as possible to minimize parenchymal infarction 1
• Success rates for renal vascular injuries treated with AE range from 82-88%, though repeat angioembolization may be required 1
• Surgical revascularization has poor outcomes with long-term kidney function preservation rates less than 25% 1

Critical caveat: If the patient becomes hemodynamically unstable despite resuscitation, or if renal venous pedicle avulsion is identified, immediate surgical intervention becomes necessary as AE is contraindicated in venous pedicle injuries 1

Acute Kidney Injury Management

This patient has severe AKI (GFR 35, creatinine 2.1, BUN 78) requiring immediate attention:

Fluid and Hemodynamic Optimization

• Aggressive fluid resuscitation to restore renal perfusion while avoiding volume overload 2
• Target adequate mean arterial pressure to maintain renal perfusion
• Monitor for fluid overload given the risk of requiring renal replacement therapy 3

Nephrotoxin Avoidance

All nephrotoxic medications must be discontinued or avoided immediately. 1

• Stop NSAIDs, aminoglycosides, and contrast agents (beyond what's necessary for the angioembolization) 1
• Avoid ACE inhibitors and ARBs during the acute phase as they can worsen filtration fraction and exacerbate AKI 1
• Review all medications and adjust dosing based on reduced GFR 1
• Regular monitoring of drug levels when available 1

Metabolic Acidosis Management

The patient has metabolic acidosis (anion gap 17) complicating AKI:

Sodium bicarbonate infusion is NOT recommended for mortality benefit but may reduce the need for renal replacement therapy. 4

• The BICARICU-2 trial (2025) showed no mortality benefit from bicarbonate infusion in severe metabolic acidemia with moderate-to-severe AKI 4
• However, bicarbonate use was associated with reduced need for kidney replacement therapy (35% vs 50%) 4
• Target arterial pH ≥7.30 if bicarbonate is administered 4
• The elevated anion gap suggests uremic acidosis from kidney dysfunction rather than a primary metabolic derangement 5

Hepatic Dysfunction Considerations

The patient has significant hepatobiliary dysfunction (total bilirubin 6.1, AST 249, ALT 97):

Hyperbilirubinemia associated with AKI significantly increases the risk of progression to chronic kidney disease. 6

• Patients with hyperbilirubinemia-associated AKI have a 32.6% one-year incidence of CKD compared to 17.8% for AKI without hyperbilirubinemia 6
• This represents a 4.5-fold increased hazard ratio for developing CKD 6
• The hepatorenal crosstalk affects drug metabolism through altered cytochrome P450 activity, requiring careful medication management 1
• Metabolic acidosis from AKI can further impair hepatic drug metabolism 1

Renal Replacement Therapy Considerations

Prepare for potential dialysis but do not initiate preemptively. 2

Indications for urgent RRT include 2:

• Refractory hyperkalemia
• Volume overload unresponsive to diuretics
• Intractable acidosis (pH persistently <7.20 despite bicarbonate)
• Uremic encephalopathy, pericarditis, or pleuritis
• Specific toxin removal

Current labs do not yet mandate immediate dialysis, but close monitoring is essential given the GFR of 35 and rising BUN 2

Monitoring and Follow-up

• Serial creatinine and electrolytes every 6-12 hours initially 2
• Continuous urine output monitoring 2
• Daily assessment of volume status and acid-base balance 1
• Imaging follow-up to assess for complications of angioembolization including post-embolization syndrome, arteriovenous fistulae, or pseudoaneurysm formation 1
• Long-term nephrology follow-up given the high risk of CKD progression with hyperbilirubinemia-associated AKI 6

Common pitfall: Do not delay angioembolization while attempting prolonged medical stabilization in a patient with ongoing hemorrhage, as this increases mortality risk. The procedure can be performed even in patients with labile hemodynamics provided the environment is adequate 1